Introduction
A growing number of human malignancies and tumorgenesis are associated with high levels of activation of signal transducers and activators of transcription (STATs), very frequently Stat3 and Stat5 (Garcia et al., 1997; Garcia and Jove, 1998; Bowman et al., 2000) . Stat3, as a major member of STAT family consisting of Stat1, 2, 3, 4, 5a, 5b, and 6, plays important roles in cell differentiation and proliferation (Darnell et al., 1994; Schaefer et al., 1995; Buettner et al., 2002) . In a variety of human cancers, constitutive activation of Stat3 is sufficient to induce cell tumorgenesis (Bromberg et al., 1999; Buettner et al., 2002) . The constitutive activation of Stat3 is frequently detected in breast cancer specimens from patients with advanced disease and breast carcinoma cell lines but not in normal breast epithelial cells (Watson and Miller, 1995; Garcia et al., 1997 Garcia et al., , 2002 . Stat3 has been classified as an oncogene because activated Stat3 can mediate oncogenic transformation in cultured cells and tumor formation in nude mice (Bromberg et al., 1999; Bowman et al., 2000; Bromberg and Darnell, 2000) . Constitutively active Stat3 signaling may participate in oncogenesis by stimulating cell proliferation, promoting angiogenesis, and conferring resistance to apoptosis induced by conventional therapies. The possible molecular mechanism of Stat3-mediated oncogenesis is related to upregulation of the Stat3-targeted genes, which are involved in cell cycle control and antiapoptosis such as Bcl-2, survivin, Mcl-1, cyclin D1, and Bcl-X L (Nielsen et al., 1999; Alas and Bonavida, 2001; Niu et al., 2002a; Liu et al., 2003; Song et al., 2004a) . However, several identified Stat3-regulated genes may not act in all functions in Stat3-mediated breast oncogenesis. We still consider that most of the Stat3-regulated genes are largely unknown during the development of breast carcinomatosis and malignancies in the presence of aberrant Stat3 signaling.
Stat3 appears to be involved in regulation of multiple systematic signal pathways and acts as multifunctional protein. For example, Stat3 deletion in mice leads to embryonic lethality (Shen et al., 2004) . It has been reported that Stat3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells (Niwa et al., 1998; Matsuda et al., 1999; Raz et al., 1999) . In breast and hemopoitic cells, existing evidences demonstrate that Stat3 acts as oncogenic protein and may be associated with chemotherapeutic resistance (Dalton and Jove, 1999; Rebbaa et al., 2001; Pollett et al., 2002; Real et al., 2002; Song et al., 2004a) . For elucidating the roles of Stat3 in breast tumorgenesis, we expressed constitutively activated Stat3 protein in nonmalignant telomerase immortalized breast epithelial (TERT) cells using adenovirus-mediated Stat3-C expression system and examined the Stat3-regulated genes, which might play roles in Stat3-mediated oncogenesis. We found that mitogen-activated protein kinase kinase 5 (MEK5) was one of the Stat3 markedly upregulated genes (more than 22-fold increase, Po0.001, Table 1 ).
The MEK5/ERK5 signal pathway was first characterized in 1995 (Zhou et al., 1995) . Currently, the function and regulation of MEK5 signaling remain to be elucidated in detail. Some reports demonstrated that MEK5 was regulated by TNFa/JNK signal pathway (Dent et al., 2003; Yoshizumi et al., 2003) . MEKK2 and MEKK3 have been demonstrated as MEK5/ERK5 direct upstream regulators (Chao et al., 1999; Chayama et al., 2001; Sun et al., 2001) . It has been proven that MEK5 acts through regulating MEF2C, a member of the MEF2 transcription factor family (Kato et al., 1997) . MEK5 consists of MEK5a and MEK5b that have masses of 50 and 40 kDa, respectively (Dent et al., 2003; Cameron et al., 2004) . In our investigation, we observed that MEK5 was highly expressed in breast carcinoma cell lines and breast cancer tissues with the presence of high Stat3 phosphorylation. Stat3 induced MEK5 protein expression and activation. Blocking of Stat3 activity inhibited MEK5 protein expression in breast carcinoma cells, implicating that MEK5 may be directly regulated by Stat3 and play an essential role in Stat3-mediated breast malignancies.
Results

Stat3 upregulated MEK5
After infection for 24 h by adenovirus Stat3-C, telomerase immortalized breast epithelial (TERT) cells were harvested and total mRNA was extracted and subjected to Affymetrix human gene focusing array analysis. Of the 8600 human focusing genes tested, the expressions of 55 genes were increased more than two fold by Stat3 with statistical significance (Po0.02). Microarray data showed that MEK5 was markedly induced (more than 22-fold increase, Po0.001) by Stat3-C in TERT cells (Table 1) . Another 14 candidate genes that may function in cell growth, cell survival, or tumor angiogenesis are also listed in Table 1 . For example, c-fos and 6-phospho-fructo-2-kinase/fructose-2,6-biphosphatatse 3 may participate in promoting cell growth (Atsumi et al., 2002; Kauraniemi et al., 2004) ; adrenomedullin may be involved in promoting cell survival, angiogenesis, and metastasis (Martinez et al., 2002; Oehler et al., 2002 Oehler et al., , 2003 ; mmp-1, mmp-10, VEGF, and cox-2 play important roles in angiogenesis and metastasis (Ueno et al., 1997; Giambernardi et al., 1998; Niu et al., 2002b; Howe and Dannenberg, 2003; Wei et al., 2003; Tan et al., 2004 We also investigated the other MEK kinase family member, MEK1/2. The result showed that MEK1/2 was not induced by Stat3-C ( Figure 1a ). For addressing whether MEK5 activation was changed while MEK5 protein was accumulating in Stat3-C overexpressed TERT cells, the lysates from TERT cells treated with different viruses as described previously were immunoprecipitated with an anti-MEK5 antibody and then immunoblotted with an anti-phospho-threonine antibody. The result demonstrated that the MEK5 phosphorylation at threonine was increased (Figure 1b) , suggesting that Stat3 stimulated MEK5 protein expression and activation in TERT cells.
MEK5 was upregulated at transcriptional level
We next determined whether MEK5 was induced by Stat3-C in the transcriptional or translational level. mRNA extracted from TERT cells was subjected to RT-PCR semiquantitative analysis. RT-PCR result showed that MEK5 mRNA was markedly induced in TERT cells infected with adenovirus Stat3-C, but not with NCV or adenovirus antisense Stat3-C ( Figure 2 ). These results are consistent with our microarray data ( Table 1 ) and suggest that Stat3 upregulates MEK5 from transcriptional level. Meanwhile Bcl-X L , a known Stat3-regulated oncogenic protein (Bromberg et al., 1999) was significantly induced in TERT cells as well ( Figure 2 ). Furthermore, MMP-1 was also induced by Stat3-C with both microarray (Table 1, 
Stat3 upregulated MEK5 expression through directly binding to the MEK5 gene promoter
According to the literature (Seidel et al., 1995; Niu et al., 2002b) , TT(N 4 )AA and TT(N 5 )AA are Stat3 general binding sequences. Therefore, 12 candidate Stat3-binding sites exist in the 3.2 kb MEK5 promoter region ( Figure 3a) . Out of 12, 10 Stat3-binding sites are located at the position from À1776 to À1037 upstream of the transcription initiation site. The sequence TTCTGGAAA between À1770 and À1762 is well identified Stat3-binding consensus sequence and fits for both TT(N5)AA and CTGGRAA category according to previous reports (Stephanou et al., 1998 (Stephanou et al., , 1999 Niu et al., 2002b) . Therefore, we selected this sequence as a major Stat3-binding site to investigate by chromatin immunoprecipitation (ChIP) assay.
To determine whether Stat3 protein could directly bind to the MEK5 promoter region within 12 candidate Stat3-binding sites in vivo, ChIP assays were performed by using a ChIP assay kit (Upstate Biotechnology, Lake Placid, NY, USA), according to the manufacturer's instruction and literature (Wells et al., 2000; Niu et al., 2002b) . Crosslinked chromatin extracted from MDA-MB-435s breast carcinoma cells was immunoprecipitated with a Stat3 antibody, followed by PCR using oligonucleotide primer pairs: 5 0 -AATGAGAGTTATAACT (forward) and 5 0 -TA-GACCACGAAACTAGAGATT (reverse) that amplify a 260 bp region spanning the Stat3-binding sites from À1776 to À1520 (four Stat3-binding sites covered in this region) within the MEK5 promoter. An approximate of 260 bp band was observed after PCR amplification. In contrast to this, immunoprecipitation with nonspecific antibody (anti-GAPDH) or no antibody resulted in the absence of such a 260 bp band, suggesting that Stat3 specifically binds with MEK5 promoter (Figure 3b ). As a negative control, mouse albumin primer pairs as described previously (Wells et al., 2000) were used for PCR reaction simultaneously.
MEK5 was reduced accompanied by the knockdown of Stat3 expression in MDA-MB-435s breast carcinoma cells
To further investigate the regulation of MEK5 by Stat3, a Stat3 knockdown approach was employed in our study. Since short interfering RNA (siRNA) oligonucleotides are increasingly utilized in gene knockdown and cancer-related studies, we used Stat3 siRNA for our investigation. Since MDA-MB-435s breast carcinoma cells contain constitutively activated Stat3 and high Stat3 phosphorylation, we utilized this cell line as our initial study cells. To achieve high transfection efficiency, an electroporation approach was employed to transfect Stat3 siRNA into MDA-MB-435s breast carcinoma cells. At least 90% transfection efficiency of GFP expression vector was observed in the same cell line with this approach (data not shown). After 72 h transfection, Stat3 protein expression and phosphorylation were significantly reduced. However, the protein levels of two other STAT family members, Stat1 and Stat5, were not affected by Stat3 siRNA. As a result of Stat3 knockdown, MEK5 protein level was markedly reduced as well (lane 3, Figure 4 ). In contrast, MEK1/2 was not affected by Stat3 knockdown. As a control, neither Stat3 nor MEK5 was affected by electrical transfection alone (lane 2, Figure 4 ).
Inhibition of MEK5 activity induced significant apoptosis in the cells with constitutively activated Stat3
Plasmid pCMV5-3Flag-MEK5KM (Xu et al., 2004) for expression of dominant negative MEK5 (dnMEK5, a After 48 h transfection, the cells were harvested and subjected to apoptosis analysis as described previously (Song et al., 2004b) . The results showed that dnMEK5 induced significant cell apoptosis ( Figure 5 ).
MEK5 was highly expressed in breast cancers and breast carcinoma cell lines
We further examined whether MEK5 level is upregulated in breast carcinoma cell lines that express constitutively activated Stat3. In MDA-MB-231, MDA-MB-435s, MDA-MB-468, SUM159, SUM1315, and SKBR-3 breast carcinoma cell lines in which Stat3 is constitutively activated, high levels of MEK5 protein were observed ( Figure 6 ). In contrast, in nonmalignant TERT and MCF-10A breast cell lines, which lack constitutively active Stat3 signaling, the levels of MEK5 protein were virtually undetectable ( Figure 6 ). As a control, MEK1/2 protein was independent with the expression of constitutively active Stat3 among the breast cell lines tested ( Figure 6 ). Furthermore, we examined the breast cancer tissues as well as normal breast tissues by using tissue array slides. We observed that 38 out of 65 cancer tissues (58.5%) were positive of phosphorylated Stat3 (tyrosine705) antibody staining and 36 out of 65 cancer tissues (55.4%) were positive of MEK5 antibody staining. The results showed that 32 out of 65 cancer tissues (49.2%) were positive of both antibodies staining ( Figure 7 and Table 2 ). Seven normal breast tissues examined were all negative of Stat3 antibody staining and only one was weakly positive of MEK5 antibody staining (Table 2) . Therefore, the results from both breast cancer cell lines and cancer tissues showed that MEK5 protein levels were highly dependent on Stat3 activation, indicating that Stat3 regulated MEK5 and Stat3-MEK5 signaling pathway might play important roles in the development of breast oncogenesis.
Discussion
Stat3 has multiple functions and plays important roles in the development of breast malignancies and tumorgenesis. Therefore, investigating the Stat3-regulated genes in breast carcinoma cells with constitutively activated Stat3 signaling could help us to best understand the Stat3 oncogenic functions. Once elucidation of Stat3 oncogenic functions and its regulated genes takes place, it could provide the potential for establishing bench markers for early breast cancer diagnosis, finding more effectively therapeutic targets, and improving chemotherapeutic prognosis ( , 2003) . For studying the Stat3-regulated genes, we established an adenovirus Stat3-C expression system to identify its potential targets. Nonmalignant TERT breast cells without Stat3 activation were employed for this study. Based on this system, we are able to investigate gene expression pattern change while constitutively active Stat3-C was introduced into TERT cells. The comparison was merely based on the difference of Stat3 expression pattern. This system makes it possible to identify the Stat3-regulated genes from both transcriptional and protein translational levels as reported previously (Song et al., 2004a) .
Our Affymetrix microarray analysis results demonstrated that the Stat3-C-expressed cells showed significant increase of MEK5 expression (Table 1 ). In terms of breast carcinoma cell lines and tissues, six out of seven breast carcinoma cell lines tested showed that MEK5 protein level was highly consistent with activated Stat3 signaling (Figure 4) . Of the 65 breast cancer tissues we investigated, 32 (49.2%) tissue samples showed that both MEK5 and Stat3 were positive (Table 2) . Furthermore, Stat3-C induced MEK5 expression and threonine phosphorylation in TERT cells. These results support that Stat3 upregulates MEK5 expression and activation.
For elucidating how Stat3 regulates MEK5, we performed ChIP assays to identify whether Stat3 could directly bind to the MEK5 promoter region. A total of 12 Stat3 candidate-biding sites are included in the approximately 3.2 kb MEK5 promoter gene region. The result from ChIP assay demonstrated that Stat3 directly bound to MEK5 promoter gene. Together, our results indicated that MEK5 was one of the Stat3 directly regulated genes and might be closely associated with breast malignancies and tumorgenesis.
Little is known about MEK5 functions. MEK5 seems to act as an oncogenic protein with aberrant Stat3 (Chayama et al., 2001; Sun et al., 2001; Nakamura and Johnson, 2003) . In our investigation, Stat3 activation did not affect MEK1/2 expression level in breast carcinoma cells. It seems unlikely that MEK5 upregulation by Stat3 is associated with MEK1/2 signaling pathway. In addition, we also identified that Interferon-a induced MEK5 expression consistent with increasing Stat3 phosphorylation in MCF7 breast cells (data not shown), implicating that Stat3 activation could induce MEK5 expression in cell culture condition. It has been proven that MEK5 functions act through regulation of its downstream kinase ERK5 (Dent et al., 2003) . It has been reported that cyclin D1 and MMP-9 are involved in malignancy and carcinomatosis in MEK5 highly activated breast and prostate carcinoma cells (Weldon et al., 2002; Mehta et al., 2003) . However, it remains to be elucidated as to how MEK5 participates in the development of breast malignancies and what role MEK5 plays with aberrant Stat3 signaling. In our investigation, MEK5 was significantly upregulated by adenovirus Stat3-C (Figure 1 ) and the phosphorylation of its downstream regulator ERK5 was induced as well (data not shown). Our RT-PCR semiquantitative analysis of MEK5 mRNA induction supports that Stat3 regulates MEK5 at transcriptional level (Figure 2) . Furthermore, MEK5 expression was markedly reduced accompanied by Stat3 knockdown in MDA-MB-435s carcinoma cells (Figure 3) . The dnMEK5 could inhibit cell growth and induce cell apoptosis in MDA-MB-435s breast carcinoma cells (Figure 5 ), suggesting that the inhibition of MEK5 activity could have the potential to reduce breast carcinoma cell tumor formation. According to these results, we may outline the partial mechanism by which MEK5 with aberrant Stat3 signaling participates in the development of breast malignancies. MEK5 activated by Stat3 signaling regulates ERK5 and other oncogenic proteins such as MMP-1, MMP-9, Bcl-XL, survivin, and cyclin D1. The aberration of Stat3-MEK5/ERK5 signaling could help breast cell to develop malignancies and confer resistance to apoptosis induced by conventional therapies. MEK5 may have clinical value for prognosis or treatment. One report showed drug-resistant MCF7 cells appeared to have significantly high level of MEK5. In that report, MEK5 contributed to prevention of cell apoptosis and chemotherapeutic resistance (Weldon et al., 2002) . There are reports that demonstrated that MEK5/ERK5 was involved in malignancies and tumorgenesis (Weldon et al., 2002; Mehta et al., 2003) . Some studies showed that the activation of MEK5/ERK5 signal pathway drove cyclin D1 and MMP-9 expression and contributed to cell carcinogenesis (Mehta et al., 2003; Mulloy et al., 2003) . MEK5 level in prostate cancer is markedly higher than that in normal tissue (Mehta et al., 2003) . Since MEK5 is highly associated with Stat3 activation in breast carcinoma cells and tissues, combining existing evidences (Weldon et al., 2002; Mehta et al., 2003) , MEK5 is, most likely, directly involved in the development of malignancies and tumorgenesis. It may also become a molecular target in the treatment of breast cancer.
Furthermore, not only MEK5 but also Stat3 may regulate other important genes that are involved in cell proliferation, survival, and tumor angiogenesis as well (Table 1) . It has been reported that c-fos and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatatse 3 participate in promoting cell growth (Atsumi et al., 2002; Kauraniemi et al., 2004) ; adrenomedullin may be involved in promoting cell survival, angiogenesis, and metastasis (Martinez et al., 2002; Oehler et al., 2002 Oehler et al., , 2003 ; mmp-1, mmp-10, VEGF, and cox-2 play important roles in invasion and metastasis (Ueno et al., 1997; Giambernardi et al., 1998; Niu et al., 2002b; Howe and Dannenberg, 2003; Tan et al., 2004) . VEGF has been previously identified as a Stat3-regulated gene (Niu et al., 2002b) . It would also be very helpful for us to understand insight mechanisms by which Stat3 signaling induces malignancies, if these candidate genes in breast cancer cells and tissues could be identified. As an oncogenic protein, Stat3 seems to regulate multiple signaling pathways. This brings up many questions. One of the very interesting questions is whether the Stat3-regulated different signaling pathways play their own roles independently or crosstalk to participate in a network regulation system during the development of malignancies. Any significant findings may potentially lead to discover new bench markers for clinical diagnosis or therapeutic targets for treating malignant breast cancer associated with aberrant Stat3 signaling.
Materials and methods
Cell lines and culture
Telomerase immortalized breast epithelial (TERT) cells, spontaneous immortalized breast cells MCF10A (Song et al., 2004a) , human breast cancer cells SUM-159, and SUM1315 were cultured in F-12 medium containing 5% FBS (Invitrogen Life Technologies, Carlsbad, CA, USA), 5 mg/ml insulin, 1 mg/ ml hydrocortisone, 5 U/ml EGF (Sigma, St Louis, MO, USA), 100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen Life Technologies, Carlsbad, CA, USA). Breast carcinoma cell lines, SK-BR-3, MDA-MB-231, MDA-MB-435s, and MDA-MB-468 were cultured in DMEM medium containing 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. All chemical reagents were purchased from Sigma (Saint Louis, MO, USA) and Fisher Scientific Companies (Pittsburgh, PA, USA) and were analytic pure grade unless otherwise indicated.
Infection of TERT and MCF10A cells by Stat3-C adenovirus
The detailed procedures were as described previously (Song et al., 2004a) . In brief, Stat3-C cDNA was cloned into an adenovirus vector, pAdCMVpLpA(À)loxP-SSP (NCV, provided by the University of Michigan Vector Core). The transcription of Stat3-C in this construct is driven by the human cytomegalovirus promoter for high-level constitutive expression. Cells (1.5 Â 10 6 ) were plated into 10-cm culture plate 2 days prior to infection. The cells were infected with NCV, anti-sense-Stat3-C adenovirus, or Stat3-C adenovirus, respectively, at a multiplicity of infection (MOI) of 50 PFU/ cell. After 5 h incubation, the culture medium was removed Plasmid pCMV5-3Flag-MEK5KM (kind gift from Dr Melanie H Cobb, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA) for expression of dominant negative MEK5 (dnMEK5) was transfected into MDA-MB-435s breast carcinoma cells by electroporation as reported previously (Song et al., 2004a) , following standard procedures and the manufacturer's instructions.
Microarray analysis
Total mRNAs were extracted from TERT cells infected with adenovirus Stat3-C, antisense-Stat3-C, or NCV. Each sample was prepared in triplicate, independently. The mRNAs were subjected to Affymetrix microarray (Santa Clara, CA, USA) human genome focus 8600 gene array analysis.
Western blot
For Western blot analysis, 100 mg of cell lysate was resolved on SDS-PAGE and transferred to a PVDF membrane. Anti-MEK5 antibody (BD Transduction Laboratories, San Diego, CA, USA), anti-MEK1/2, anti-phos-Stat3 (Tyrosine705), antiStat3, anti-Stat1, anti-Stat5, anti-phospho-threonine (Cell Signaling Inc., Beverly, MA, USA), and anti-GAPDH (Biochemistry Lab, Temecula, CA, USA) antibodies were used to detect corresponding proteins on the membrane, respectively.
Immunoprecipitation
Immunoprecipitation was performed in a standard procedure as described previously (Bhat and Zhang, 1999; Okano and Rustgi, 2001 ). In brief, 10 mg of anti-human MEK5 antibody was added to 500 mg of total protein from cell lysates and incubated for 2 h at 41C with gentle agitation. Then, 50 ml of protein A agarose beads (Invitrogen Life Technologies, Inc., Carlsbad, CA, USA) were added to immune complexes, followed by incubation for another 2 h at 41C. The samples were briefly centrifuged and the supernatants were discarded. The beads were then washed twice with RIPA lysis buffer and were boiled in 50 ml of 2 Â SDS sample buffer for 5 min. The soluble proteins were resolved on a SDS-PAGE and transferred to a PVDF membrane. Immunoblotting was performed to detect relevant proteins by using procedures similar to those described above.
Apoptotic assay
To quantitate the induction of apoptosis by dnMEK5 in the Stat3 active cancer cells, MDA-MB-435s cells were plated with 3 Â 10 5 cells per 6-cm diameter dish 1 day prior to transfection. After 48 h transfection with dnMEK5, the cells were harvested and fixed with 70% ethanol. Then, the cells were stained with propidium iodide (PI) and analysed for the reduction of DNA content (Sub-G1 profile) using software on a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA). Results are based on average values and standard deviations from three separate experiments.
ChIP assays
To detect Stat3 binding with MEK5 promoter region, a ChIP assay kit (Upstate Biotechnology, Lake Placid, NY, USA) was employed in this study. The assay was conducted as reported previously (Wells et al., 2000; Niu et al., 2002b) and according to the manufacturer's instruction. The primer pairs, 5 0 -AATGAGAGTTATAACT (forward) and 5 0 -TAGACCAC-GAAACTAGAGATT (reverse), were synthesized by QIA-GEN company (Valencia, CA, USA).
RT-PCR analysis
mRNA was prepared by using Invitrogen one-step mRNA extraction kit. Primers for MEK5: 5 0 -GCCTGCGGGTGCG TTCCT (sense), 5 0 -TCAATGCCCCACCCTTTACCTCTC (antisense); for MMP-1: CTGCTGTTCTGGGGTGTGGTG (sense), TTCCTCCGGCAAAGACTCAT (antisense); for Bcl-XL: CCGGGAGCTGGTGGTTGACTTTC (sense), ATGG CGGCTGGACGGAGGAT (antisense),were synthesized by QIAGEN company (Valencia, CA, USA). RT-PCR was performed using one step RT-PCR kit (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instruction.
Stat3 knockdown by siRNA
SMARTpoolt of Stat3 short interfering RNA (Stat3 siRNA) oligonucleotides were purchased from Dharmacon, Inc. (Lafayette, CO, USA). Stat3 siRNA containing mixed sequences (GACCUGCAGCAAUA, GAGAAGCAUCGU GA, UUUGGUGUUUCAUA, UCAGGUUGC-UGGUC) was transfected into MDA-MB-435s cells by electroporation approach according to the manufacturer's instruction. After 72 h, the cells were harvested and lysed for Western blot analysis. pEGFP-C1 vector (BD Clontech, Palo Alto, CA, USA) was used as a positive control to determine the transfection efficiency.
Tissue array analysis
Human breast cancer tissue array slides were obtained from the National Cancer of Institutes (Philadelphia, PA, USA) and Chemicon International, Inc. (Temecula, CA, USA). Immunostaining was conducted by using Chemicon IHC Selectt detection system (Temecula, CA, USA). The array slides were stained and probed by using relevant antibodies according to standard procedures and the manufacturer's instructions.
